As endothelial cells are the major source of PAI-1 and involved in different cardiovascular diseases [8-17], we choose to use endothelial cells to study the effect of PAI-1 inhibitor on Doxorubicin-induced ROS and ROS quenching factors. Here, SERPINE1 is linked to cardiovascular disorder.